PUBLIC COMPANY
saveRecordati Rare Diseases Inc
updated 4mo ago
community read0 votes
pipeline
10
marketed
9
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(10)
pipeline depth10 products
1Phase 29Marketed
Marketed
betaine hydrochloride
Homocystinuria
Marketedcarglumic acid ODT
Hyperammonemia
Marketedclorazepate dipotassium
Alcohol Withdrawal Syndrome
Marketedhemin (human)
Acute Intermittent Porphyria
Marketedibuprofen lysine
Patent Ductus Arteriosus
Marketedmetamfetamine
Attention Deficit Hyperactivity Disorder (ADHD)
Marketedosilodrostat phosphate
Pituitary ACTH Hypersecretion (Cushing Disease)
Marketedpasireotide LA
Acromegaly
Marketedsuccimer
Lead Poisoning
Phase 2PROPRANOLOL HYDROCHLORIDE
Retinopathy Of Prematurity
Beta-2 adrenergic receptorBeta-1 adrenergic receptor
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that